Higher red blood cell distribution width at diagnose is a simple negative prognostic factor in chronic phase-chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: A retrospective study

The aim of this study was to evaluate the ability of the red blood cell distribution width (RDW) to predict prognosis and treatment response in chronic myeloid leukemia (CML)-chronic phase (CP) patients treated with tyrosine kinase inhibitor (TKIs). We retrospectively enrolled 93 newly diagnosed CML...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Xia-Li, Xi, Ya-Ming, Li, Zi-Jian, Jia, Ming-Feng, Li, Ming, Wang, Li-Na, Zhao, Long, Zhang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969257/
https://www.ncbi.nlm.nih.gov/pubmed/33725811
http://dx.doi.org/10.1097/MD.0000000000024003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969257/
https://www.ncbi.nlm.nih.gov/pubmed/33725811
http://dx.doi.org/10.1097/MD.0000000000024003

Ejemplares similares